Matches 1 - 50 out of 192 1 2 3 4 >


Match Document Document Title
US20130296427 NERAMEXANE FOR THE TREATMENT OR PREVENTION OF TINNITUS RELATED WITH STRESS OR ACUTE HEARING LOSS  
Nerarnexane or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of tinnitus, wherein said neramexane or a pharmaceutically acceptable salt thereof is administered...
US20110064720 Dietary Supplement Compositions and Methods of Making and Using the Same  
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed.
US20110236439 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane  
The present invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable...
US20120065261 Creatine compositions for skin treatment  
The present invention relates to the use of creatine compounds, such as, for example, creatine monohydrate, creatine pyruvate and creatine ascorbate, for the treatment of skin.
US20060263399 Preparation for external use on skin  
The present invention has as an object to provide a preparation for external use on skin in which a water-soluble ascorbic acid can be stably dissolved. By blending a low molecular weight betaine...
US20050256192 Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual  
A nutritional composition, the consumption of which provides a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance,...
US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds  
An inexpensive, easily available, and convenient method of treating or preventing a virus infection is provided. The present invention relates to a method for the treatment or prevention of virus...
US20110229570 ORALLY RAPIDLY DISINTEGRATING TABLET AND PROCESS FOR PRODUCING SAME  
Disclosed is an orally rapidly disintegrating tablet characterized in that the tablet can be produced in a conventional tablet manufacturing facility and has a satisfactory level of hardness for...
US20120115950 ABUSE-RESISTANT AMPHETAMINE PRODRUGS  
The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for...
US20050288371 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis  
The present invention relates to the use of gaboxadol for the preparation of medicaments useful for the treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis.
US20150164826 Dosage Forms and Related Therapies  
This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more...
US20120070472 CHRONOTHERAPEUTIC COMPOSITIONS AND METHODS OF THEIR USE  
Chronotherapeutic formulations of cardiovascular drugs are disclosed. The formulations comprise at least one cardiovascular drug that exhibits an in vivo elimination half-life of less than about 8...
US20070265339 STORAGE-STABLE AQUEOUS COMPOSITION COMPRISING A MAGNESIUM COMPOUND AND L-CARNITINE  
The present invention relates to a storage-stable aqueous or gel-like composition or solution comprising a magnesium compound selected from a magnesium salt or a magnesium complex compound, and...
US20100047360 Use Of Polyamines In The Treatment Of Psoriasis  
The present invention provides unbranched aliphatic polyamines for use in therapy, particularly for use in the treatment of psoriasis and compositions containing polyamines.
US20070043115 Use of choline to prevent thrombosis associated with total parenteral nutrition  
Choline deficiency is a risk factor for the development of thrombosis in patients with intestinal failure that require total parenteral nutrition. There is provided a method of preventing...
US20110086916 INTERVAL THERAPY FOR THE TREATMENT OF TINNITUS  
The present invention relates to interval and/or maintenance therapy employing 1-amino-alkylcyclohexane derivatives (e.g., neramexane or a pharmaceutically acceptable salt thereof) for the...
US20070280996 Dietary supplement having improved efficacy at time of consumption  
A dietary supplement that includes a container having a first compartment and a second compartment. The first compartment includes an aqueous medium. The second compartment includes an ingredient...
US20080063689 Dietary supplements containing anthocyanins and methods for using same to enhance creatine absorption and vasodilation  
A problem with optimizing the effects of creatine has been the need to utilize large amounts of high glycemic carbohydrates to spike insulin in order to augment the flow of creatine (and other...
US20140005616 WOUND CARE ARTICLES  
Single layer and multi-layer anti-microbial wound care fabrics, gloves, sleeves, anklets, socks, finger cots, masks, and similar wound care articles are disclosed.
US20090042983 Use of L-carnitine for the treatment of cardiovascular diseases  
The use of L-carnitine or one of its pharmaceutically acceptable salts is described for the preparation of a medicine useful for reducing the number of deaths caused by acute myocardial infarction...
US20120196933 MEXILETINE PRODRUGS  
The present invention concerns prodrugs of mexiletine (and mexiletine's active metabolite) pharmaceutical compositions containing such prodrugs. Methods for treating myotonic conditions, while...
US20120003310 DELAYED RELEASE RASAGILINE FORMULATION  
Disclosed are formulations of rasagiline base which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. Also, disclosed are rasagiline citrate salt...
US20060198899 Supplemental dietary composition for supporting muscle growth, recovery and strength  
Methods and compositions for the purposes muscle growth, recovery and/or strength are set forth. The compositions may include, but are not limited to, creatine monohydrate, glutamine...
US20050239887 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes  
Pharmaceutical compositions of the active substances glimepiride with metformin or its salts such as hydrochloride, succinate, furmarate, etc. are useful to control blood glucose in patients with...
US20140194510 DISPERSIONS OF RASAGILINE CITRATE  
The subject invention provides a solid dispersion of rasagiline citrate, a composition and a process for the manufacture thereof.
US20120059058 DISPERSIONS OF RASAGILINE CITRATE  
The subject invention provides a solid dispersion of rasagiline citrate, a composition and a process for the manufacture thereof.
US20060177501 Film Coated Tablets Containing Ibuprofen  
The invention relates to film-coated tablets containing ibuprofen lysinate with improved stability, bioavailability and higher acceptance (compliance) in patients, and the use of these film-coated...
US20060233892 Topiramate compositions for treatment of headache  
A composition containing from about 10 to about 50 mg of topiramate in combination with one or more of parthenolide, magnesium and riboflavin is effective for treating headaches, and particularly...
US20060223791 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof  
A combination product containing at least two active compounds, O-desmethylvenlafaxine or a pharmaceutically acceptable salt thereof and bazedoxifene or a pharmaceutically acceptable salt thereof...
US20070116696 Lotus and methyl donors  
Cosmetic, dermatological and dietary compositions for treatment of aging of the skin are provided that contain a compound useful in promoting skin health and youthful appearance, such as extract...
US20070293571 ADMINSTRATION OF DOPA PRECURSORS WITH SOURCES OF DOPA TO EFFECTUATE OPTIMAL CATECHOLAMINE NEUROTRANSMITTER OUTCOMES  
A method of treating neurotransmitter dysfunction in a patient by optimizing catecholamine levels by administration of L-3,4-dihydroxyphenylalanine (L-Dopa or Dopa) precurors in combination with a...
US20140079809 COMPOUNDS USEFUL FOR THE PREVENTION OR TREATMENT OF ACCOMMODATIVE ASTHENOPIA  
The use of L-carnitine, in combination with antioxidants such as vitamin E and inorganic elements such as manganese, zinc, sodium and potassium, for the preparation of a physiological supplement...
US20070072927 NUTRITIONAL SUPPLEMENT FOR INCREASED ENERGY AND STAMINA  
In a method of treating hypertension in individuals suffering therefrom, the method includes administering to said individuals an effective amount of carnitine and an effective amount of lipoic...
US20070185200 Screen for pre-eclampsia  
It has been demonstrated that the level of asymmetric dimethylarginine (ADMA) increases in women that subsequently develop pre-eclampsia or whose fetus subsequently develops intrauterine growth...
US20070248690 Composition and methods for alleviating symptoms of neurotoxicity  
A composition for alleviating symptoms associated with neurotoxicity. The composition may comprise compounds for preventing glutamate mediated neurotoxicity. The composition may include one or...
US20060269598 Antihistaminic/Decongestant/Anticholinergic Compositions and Methods of Use  
Compositions comprising essentially of methscopolamine in combination with tannate compounds which are effective when administered orally for the symptomatic relief of symptoms associated with...
US20120288532 MULTI-LAYERED, MULTIPLE UNIT PHARMACEUTICAL COMPOSITIONS  
The invention relates to pharmaceutical compositions comprising multilayered multiple units and processes for the preparation thereof.
US20080103111 Smoking Cessation Treatment with Appetite Suppression  
A multi-component compound for the simultaneous treatment of nicotine addiction and the side effects of nicotine withdrawal, such as excessive appetite. The first component is a bivalent negative...
US20070065456 Nutritional supplements  
Nutritional supplement formulations are disclosed, such as nutritional supplement formulations that include Wasabia japonica. Methods for using the same to supplement a human diet are also disclosed.
US20070036846 Wound dressing and method of manufacture thereof  
A hydrogel dressing for covering or treating a wound, a surgical incision, a catheter insertion site or the like, comprising a non-fluid sheet material including a structure of cross-linked...
US20050096392 Use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion  
The invention relates to the use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion. Said use is to be applied in particular during short-term...
US20070025948 Dilution-type sterilizer composition  
The present invention provides a germicidal antiseptic composition for dilution, which is superior in preparation stability, and free of formation of insoluble precipitation even when diluted with...
US20070213399 MODULATION OF NITRIC OXIDE SYNTHASES BY BETAINES  
The present invention relates to therapeutic compositions of betaines and L-arginine and physiologically acceptable salts thereof, and to pharmaceutical uses of betaines for up-regulating,...
US20050250849 Basic amino acid - methionine hydroxy analog compositions  
Simple, cost-effective and convenient compositions comprising basic amino acids and 2-hydroxy-4-methylthiobutanoic acid (HMBA) are disclosed. The compositions have many uses, including as food...
US20110313040 ORGANIC NUTRIENT SALTS, METHODS OF PREPARATION AND USES  
The invention relates to organic nutrient salts, to compositions containing the same, to their preparation as well as their use. Preferred compositions include nutraceutical compositions and...
US20070191287 D-ribose for improving depression-like symptoms  
An agent for improving depression-like symptoms comprising D-ribose, which may improve an alleviate various symptoms such as hypobulia, general fatigue, sluggishness, enervation, deterioration in...
US20050069585 Diphenhydramine tannate liquid and semi-solid compositions and methods of use  
Pharmaceutical compositions consisting of diphenhydramine tannate which are effective when administered for the symptomatic relief of sneezing, itchy, watery eyes, itchy nose or throat and runny...
US20070021376 Supplement composition and method of use in enhancement of methylation process  
A supplement composition for enhancement of methylation process is provided, which contains vitamin B6 (as pyridoxine HCl), folic acid, vitamin B12 (as cyanocobalamin), betaine HCl, and...
US20050152846 Formoterol superfine formulation  
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting β2-agonist by inhalation. In particular this invention relates to a chemically stable...
US20110071120 SOLID STATE FORMS OF TAPENTADOL SALTS  
Provided herein are novel solid state forms of tapentadol salts, process for their preparation, pharmaceutical compositions, and method of treating thereof. The tapentadol salts include an...

Matches 1 - 50 out of 192 1 2 3 4 >